Logo image of ASTS

AST SPACEMOBILE INC (ASTS) Stock Fundamental Analysis

NASDAQ:ASTS - Nasdaq - US00217D1000 - Common Stock - Currency: USD

28.64  -2.99 (-9.45%)

After market: 28.6001 -0.04 (-0.14%)

Fundamental Rating

2

ASTS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 32 industry peers in the Diversified Telecommunication Services industry. The financial health of ASTS is average, but there are quite some concerns on its profitability. ASTS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ASTS has reported negative net income.
In the past year ASTS has reported a negative cash flow from operations.
ASTS had negative earnings in 4 of the past 5 years.
In the past 5 years ASTS always reported negative operating cash flow.
ASTS Yearly Net Income VS EBIT VS OCF VS FCFASTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -50M -100M -150M -200M -250M

1.2 Ratios

The Return On Assets of ASTS (-36.04%) is worse than 93.55% of its industry peers.
ASTS has a Return On Equity of -95.87%. This is amonst the worse of the industry: ASTS underperforms 93.55% of its industry peers.
Industry RankSector Rank
ROA -36.04%
ROE -95.87%
ROIC N/A
ROA(3y)-12.79%
ROA(5y)-12.45%
ROE(3y)-47.54%
ROE(5y)-34.67%
ROIC(3y)N/A
ROIC(5y)N/A
ASTS Yearly ROA, ROE, ROICASTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ASTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASTS Yearly Profit, Operating, Gross MarginsASTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

More info and screens

5

2. Health

2.1 Basic Checks

ASTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ASTS has more shares outstanding
The debt/assets ratio for ASTS is higher compared to a year ago.
ASTS Yearly Shares OutstandingASTS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M 200M
ASTS Yearly Total Debt VS Total AssetsASTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

ASTS has an Altman-Z score of 8.62. This indicates that ASTS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.62, ASTS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.51 indicates that ASTS is somewhat dependend on debt financing.
ASTS has a Debt to Equity ratio of 0.51. This is in the better half of the industry: ASTS outperforms 70.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF N/A
Altman-Z 8.62
ROIC/WACCN/A
WACC9.06%
ASTS Yearly LT Debt VS Equity VS FCFASTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M -100M 200M -200M

2.3 Liquidity

ASTS has a Current Ratio of 5.80. This indicates that ASTS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ASTS (5.80) is better than 100.00% of its industry peers.
ASTS has a Quick Ratio of 5.80. This indicates that ASTS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 5.80, ASTS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.8
Quick Ratio 5.8
ASTS Yearly Current Assets VS Current LiabilitesASTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ASTS have decreased strongly by -152.38% in the last year.
The Revenue for ASTS has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)-152.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-378.26%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 53.20% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-49.02%
EPS Next 2Y16.07%
EPS Next 3Y21.66%
EPS Next 5Y53.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASTS Yearly Revenue VS EstimatesASTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
ASTS Yearly EPS VS EstimatesASTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 20 40 60

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASTS. In the last year negative earnings were reported.
Also next year ASTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASTS Price Earnings VS Forward Price EarningsASTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASTS Per share dataASTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as ASTS's earnings are expected to grow with 21.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.07%
EPS Next 3Y21.66%

More info and screens

0

5. Dividend

5.1 Amount

ASTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AST SPACEMOBILE INC

NASDAQ:ASTS (2/21/2025, 8:02:01 PM)

After market: 28.6001 -0.04 (-0.14%)

28.64

-2.99 (-9.45%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)03-03 2025-03-03/amc
Inst Owners38.12%
Inst Owner Change-97.88%
Ins Owners1.52%
Ins Owner Change0.51%
Market Cap8.30B
Analysts81.82
Price Target34.88 (21.79%)
Short Float %28.07%
Short Ratio4.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-276.67%
Min EPS beat(2)-426.06%
Max EPS beat(2)-127.27%
EPS beat(4)1
Avg EPS beat(4)-143.51%
Min EPS beat(4)-426.06%
Max EPS beat(4)25.3%
EPS beat(8)4
Avg EPS beat(8)-62.22%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-95.66%
Min Revenue beat(2)-95.8%
Max Revenue beat(2)-95.53%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.84%
PT rev (3m)-4.84%
EPS NQ rev (1m)-45.83%
EPS NQ rev (3m)-45.83%
EPS NY rev (1m)-13.18%
EPS NY rev (3m)-39.14%
Revenue NQ rev (1m)-45.14%
Revenue NQ rev (3m)-45.14%
Revenue NY rev (1m)-15.89%
Revenue NY rev (3m)-85.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3319.15
P/FCF N/A
P/OCF N/A
P/B 26.86
P/tB 26.86
EV/EBITDA N/A
EPS(TTM)-2.12
EYN/A
EPS(NY)-0.69
Fwd EYN/A
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS0.01
BVpS1.07
TBVpS1.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.04%
ROE -95.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-12.79%
ROA(5y)-12.45%
ROE(3y)-47.54%
ROE(5y)-34.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 153.67%
Cap/Sales 4577.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.8
Quick Ratio 5.8
Altman-Z 8.62
F-Score2
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)1105.69%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-152.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-378.26%
EPS Next Y-49.02%
EPS Next 2Y16.07%
EPS Next 3Y21.66%
EPS Next 5Y53.2%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.21%
EBIT Next 3Y65.51%
EBIT Next 5Y81.26%
FCF growth 1Y-16.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.21%
OCF growth 3YN/A
OCF growth 5YN/A